Back to CONGRESS ASSET MANAGEMENT CO CONGRESS ASSET MANAGEMENT CO

LGNDLGND
17 quarters

Position history for CONGRESS ASSET MANAGEMENT COCONGRESS ASSET MANAGEMENT CO's holdings in LIGAND PHARMACEUTICALS

CONGRESS ASSET MANAGEMENT CO holds 659,911 shares of LGND (LIGAND PHARMACEUTICALS), worth $208.6M as of 2026-Q2. The position was increased (+30.8% shares). LGND represents 1.3% of CONGRESS ASSET MANAGEMENT CO's portfolio.

Current Value

$208.6M

Current Shares

659,911

Total Value Change

+$205.8M

Total Shares Change

+637,560

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
659,911
+30.8%
$208.6M1.3%$316.09
61
2026-Q1
Increased
504,637
+5.1%
$100.8M0.7%$204.24
44
2025-Q4
Decreased
480,063
-28.1%
$90.8M0.6%$190.20
0
2025-Q3
Increased
667,311
+3.0%
$118.2M0.8%$173.13
44
2025-Q2
Increased
647,941
+0.8%
$73.7M0.5%$114.15
42
2025-Q1
Increased
642,712
+3.4%
$67.6M0.5%$107.62
43
2024-Q4
Increased
621,482
+2.9%
$66.6M0.5%$105.76
36
2024-Q3
Increased
604,038
+3.0%
$60.5M0.4%$97.37
36
2024-Q2
New
586,624
-
$49.4M0.4%$84.26
48
2020-Q4
Exited
0
-100.0%
$00.0%$64.02
0
2020-Q3
Increased
32,375
+4.6%
$3.1M0.0%$59.76
28
2020-Q2
Increased
30,947
+2.2%
$3.5M0.0%$70.51
27
2020-Q1
Increased
30,292
+58.8%
$2.2M0.0%$44.42
37
2019-Q4
Decreased
19,079
-25.4%
$2M0.0%$64.87
0
2019-Q3
Increased
25,563
+6.7%
$2.5M0.0%$61.73
28
2019-Q2
Increased
23,966
+7.2%
$2.7M0.0%$71.21
28
2019-Q1
New
22,351
-
$2.8M0.0%$78.42
36

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used